Novel route for preparing dolutegravir key intermediate 2,4-difluorobenzylamine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 浙江沙星科技股份有限公司
- Publication Date
- 2018-11-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of synthesis of medicines and pesticide chemicals, and the specific content is a new synthesis route of 2,4-difluorobenzylamine, a key intermediate of dolutegravir. Background technique
[0002] 2,4-Difluorobenzylamine is a very important chemical intermediate, and its most important use is to prepare the anti-AIDS drug dolutegravir. Dolutegravir is a new type of integrase inhibitor developed by GlaxoSmithKline and approved for marketing in the United States in 2013. Due to its advantages of high efficiency and low toxicity, the market sales have risen rapidly in recent years, and the momentum is unanimously optimistic. Among the several known synthetic routes of dolutegravir, 2,4-difluorobenzylamine is a key intermediate that cannot be bypassed. Therefore, it is very meaningful to develop an efficient, green and low-cost preparation process for 2,4-difluorobenzylamine.
[0003] At present, the production industry ...